Healthcare | May 17, 2022
They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
The company also raised Rs 270 crore investment from Temasek in 2019
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients
The aim is to bring patient consent tools in a digital format in addition to a paper format which is not just a need of the current times but also a way forward
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
Subscribe To Our Newsletter & Stay Updated
